Awanui Group

In our latest update on the research being led by Microbiologist Dr Max Bloomfield and his team, which examines how laboratory guidance can inform appropriate prescribing of antibiotic treatments 💊 - we learn wound swab cultures 🧫 are causing a lot of unnecessary antibiotic use. With a change to how the result is reported from the lab, the study showed an almost 50 percent reduction in patients being dispensed antibiotics. For the details check out this story on our website here: https://lnkd.in/gEY4JRyg

Phlebotomy Trainer Ailish Treacy has been busy reshaping the phlebotomy training course which Awanui Labs provides for our staff and external health providers in the Northern region. Moving the theory and compliance components to an online course is making it more accessible, easier and more fun for health providers like Turuki Health Care to train their staff to collect blood samples from patients. You can read more here 👉 https://lnkd.in/gphF_v_Q

Awanui Labs recently took part in a Health New Zealand | Te Whatu Ora study on effective ways to get verbal consent from patients for Hepatitis C screening when they visit a collection centre.  The study is part of Health NZ’s National Hepatitis C Action Plan aimed at developing large-scale testing and screening programme and the elimination of the disease by 2030. Read about it here: https://lnkd.in/gKvy3vqr

It was a huge unknown as to how many women would take up the option of the new swab method for cervical cancer screening before the programme went live, however this option has proven popular with approximately 75% of the samples received for HPV testing being from this swab method. Remarkably, in the first six months of the programme, 20 percent of the tests performed across the country were from women who had never been screened, or were outside the screening interval, for cervical cancer.  We expect to see high volumes continuing, and with each swab, another person can screen for early signs of cancer which can save lives. https://lnkd.in/gYUp5HTs #cervicalcancer #HPVscreening

Along with other funded-sector providers Pathlab and Medlab Central, we're proposing a new way of doing things in pathology in Aotearoa New Zealand. We have four focus areas - Service, Workforce, Sector, and Funding. Below is what we see is a better future for the way we provide and benchmark services. Learn more at https://lnkd.in/gTHNuF_Y

Awanui Group CEO Anoop Singh sat down with Wing Lam Wong, General Manager of Roche Diagnostics New Zealand to discuss how partnerships with suppliers, community groups, government and other key stakeholders are integral to the services that Awanui Group provides. In Part 2 Anoop shares detail on our business transformation journey. Find Part 1 here: https://lnkd.in/gpQEXCky Roche Diagnostics Asia Pacific

Over many decades, Aotearoa’s pathology laboratory sector has served our communities well. However, what we see today is a structure that has produced a range of geographical and service inconsistencies for Kiwis. Awanui Group, along with other funded-sector providers have documented our position on what the pathology sector needs to do and look like to deliver aspirations of a consistent, well-resourced and patient-centred service. ➡ Learn more about this at https://lnkd.in/gdK8fHnc ➡ Or you can find our position paper here: https://lnkd.in/gCKcnB5j Over the coming weeks we'll be sharing the details of the paper here on our LinkedIn page. #FutureofPathology

Last year, Awanui Clinical Microbiologist Max Bloomfield discussed how genome sequencing technology had led to the early detection and containment of an outbreak of Clostridioides difficile infection (CDI) at Wellington Regional Hospital in 2022.  In the latest stage of their research, Max and the team sought to better understand the outbreak and demonstrate how the early detection and subsequent changes to prevention and control measures prevented further spread. The research shows that without the genome sequencing using the MinION, the outbreak would have gone unnoticed.  Read more here>> https://lnkd.in/g45ZEWur

Early bird tickets are now open for CoLab 2024: New Zealand's Lab Sector Forum on 25 - 26 September in Wellington. Get in early for your tickets: https://www.colabforum.nz/ Thank you to our Premium Sponsors Hologic, Inc. Innovation Sponsor Roche Diagnostics Asia Pacific Gold Sponsor Mediray NZ And the other fantastic lab businesses that make Co:Lab possible Lab Supply, Mediscope International Ltd, BD, SATO New Zealand Ltd, Cepheid

Awanui Labs this year completed the final phase of Project NOVA, the deployment of a single core information system for the organisation’s human pathology laboratories across the country.  We sat down with CIO Brent Glanville on the project, which began with the first meeting in December 2017.  https://lnkd.in/gs5diNPR “The time it has taken to complete the roll-out really shows the huge amount of work, perseverance and effort by our people and the challenge of completing project of this scale and complexity. Once you start, you have no ability to row back, and must keep going. Even though the project has been a success, you never quite know until it goes live.